Built on a nationally accredited, cutting-edge research environment,
we are setting a new standard in future medicine through integrated stem cell and genetic research.
Restoring fundamental function beyond
the limits of medication and surgery
For severe eye conditions that were once difficult to treat,
new possibilities are now opened through human-derived cell therapies.
Advanced regenerative medicine is an innovative approach that uses human cells to regenerate
and restore damaged tissues and functions. By combining cell therapy, gene therapy, and tissue engineering,
it aims to repair ocular tissues and improve vision. Since the eye is an “immune-privileged” organ with a lower risk of rejection,
ophthalmology is one of the leading fields in regenerative medicine research worldwide.

(Limited to symptom relief and ‘maintenance’)
Stem Cell Therapy
Gene Therapy
Transplant (stem cells, immune cells)
A trusted leader in regenerative medicine,
verified by rigorous national standards
To be designated as an advanced regenerative medicine provider, institutions must meet strict standards for facilities, equipment,
medical expertise, and clinical research protocols. At Seoul BGSS Eye Clinic, all key personnel have completed specialized training,
and all research and treatments are conducted under strict government oversight to ensure safety and reliability.
Government-Verified Strict Standards

State-of-the-Art Research Facilities

High-Precision Research Equipment

Highly Experienced Medical Professionals

Standard Operating Procedures (SOPs)

Ministry of Health and Welfare Evaluation
Opening New Pathways for Treatment in 2026
For intractable eye diseases that have shown limitations with conventional medication or surgery,
we provide next-generation medical solutions aimed at fundamental tissue regeneration
Advanced Regenerative Medicine Provider Institution
Principal Investigator: Dr. Jong-Ho Lee, Chief Director